Silgan Dispensing Introduces Gemini™ BE Nasal Pump

January 16, 2023

Silgan Dispensing

Silgan Dispensing announces the launch of the Gemini™ BE nasal pump, a solution of nasal spray for pharmaceutical brands.

Developed with Silgan Dispensing's Bioequivalence (BE) program, the Gemini™ BE Nasal Pump is customizable to effectively match specific formulations for a perfect performance fit and rapid time to market. Gemini™ allows for maximum customization with over 40 different spray settings.

Additional benefits of the Gemini™ BE Nasal Pump are: ISO certified, pharmaceutical grade, clean room production, high dosing accuracy, ability to match existing Reference Listed Drug (RLD) devices in a variety of formulations and to modify spray characteristics such as DSD, plume geometry, and spray pattern.

Silgan Dispensing's BE program is aligned with US FDA and EU methods, giving customers the confidence they need from a healthcare packaging supplier. In addition, the BE program is supported by the Silgan Dispensing regulatory team, which utilizes the company's cGMP nasal spray testing laboratory and equipment, and partners with accredited third-party cGMP laboratory testing services and CMOs for nasal products. .

You may be interested in continuing reading ...

Translate »